Zotiraciclib, a New Treatment for Glioma, is Granted Orphan Drug Designation
Source: Pixabay.com

Zotiraciclib, a New Treatment for Glioma, is Granted Orphan Drug Designation

  The European Organization for Research and Treatment of Cancer (EORTC) has been evaluating zotiraciclib, which is a new treatment for glioma. This drug has recently been granted the Orphan…

Continue Reading Zotiraciclib, a New Treatment for Glioma, is Granted Orphan Drug Designation
FDA Grants Orphan Drug Designation for Treatment of Pancreatic Neuroendocrine Tumors
source: pixabay.com

FDA Grants Orphan Drug Designation for Treatment of Pancreatic Neuroendocrine Tumors

  Surufatinib was recently granted Orphan Drug designation by the FDA. This drug was made for the treatment of pancreatic neuroendocrine tumors (PanNETs). It was created by Hutchison China MediTech…

Continue Reading FDA Grants Orphan Drug Designation for Treatment of Pancreatic Neuroendocrine Tumors
New Center for Research of Primary Sclerosing Cholangitis Created in Boston
Fall is a GREAT time of year to visit Boston--and you feel AWESOME about helping to raise funds for PI! [Source: pixabay.com]

New Center for Research of Primary Sclerosing Cholangitis Created in Boston

Copyscape score: 2% Brigham and Women's is launching the nation's first ever center to conduct research on primary sclerosing cholangitis, a rare liver disease that affects about 30,000 people in…

Continue Reading New Center for Research of Primary Sclerosing Cholangitis Created in Boston
Study: Viking Therapeutics Evaluates VK2809 for Treatment of Non-Alcoholic Steatohepatitis (NASH)
luvqs / Pixabay

Study: Viking Therapeutics Evaluates VK2809 for Treatment of Non-Alcoholic Steatohepatitis (NASH)

  The FDA has recently approved of Viking Therapeutics' Investigational New Drug (IND) application, which allows patients to enroll in their clinical trials. In order to qualify for these trials,…

Continue Reading Study: Viking Therapeutics Evaluates VK2809 for Treatment of Non-Alcoholic Steatohepatitis (NASH)

New Treatment Shows Benefits for Patients with Sickle Cell Disease and Beta Thalassemia

  New knowledge of the genes that affect sickle cell disease and beta thalassemia has allowed for advances in treatments for these diseases. Advances in technology have also helped with…

Continue Reading New Treatment Shows Benefits for Patients with Sickle Cell Disease and Beta Thalassemia
OTL-200 Granted Accelerated Assessment for Treatment of Metachromatic Leukodystrophy (MLD)
source: pixabay.com

OTL-200 Granted Accelerated Assessment for Treatment of Metachromatic Leukodystrophy (MLD)

  The development of treatments and medicines for diseases can take a long time. These treatments come from many hours of research, studies, trials, and waiting for approval from the…

Continue Reading OTL-200 Granted Accelerated Assessment for Treatment of Metachromatic Leukodystrophy (MLD)
Kate Middleton Visits Boys with Hunter Syndrome and Dystonic Cerebral Palsy
source: pixabay.com

Kate Middleton Visits Boys with Hunter Syndrome and Dystonic Cerebral Palsy

  East Anglia's Children's Hospices in Norfolk, U.K., has recently opened up its new facilities after renovations. To celebrate this opening, Kate Middleton, the Duchess of Cambridge, visited and spoke…

Continue Reading Kate Middleton Visits Boys with Hunter Syndrome and Dystonic Cerebral Palsy